What is Beam Therapeutics's net investment in lease?

Beam Therapeutics (BEAM) reported net investment in lease of $98.15M in Q1 2026.

How has Beam Therapeutics's net investment in lease changed year-over-year?

Beam Therapeutics's net investment in lease decreased by 4.0% year-over-year, from $102.22M to $98.15M.

What is the long-term trend for Beam Therapeutics's net investment in lease?

Over 5 years (2020 to 2025), Beam Therapeutics's net investment in lease has grown at a 3.0% compound annual growth rate (CAGR), from $86.86M to $100.68M.

Beam Therapeutics BEAM Net Investment in Lease

Net Investment in Lease at other companies

Vertex PharmaceuticalsVRTX

——

Arrowhead ResearchARWR

——

CRISPR TherapeuticsCRSP

——

Cogent Biosciences, Inc.COGT

——

PTC TherapeuticsPTCT

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.42B+24.5%

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's net investment in lease?: Beam Therapeutics (BEAM) reported net investment in lease of $98.15M in Q1 2026.
How has Beam Therapeutics's net investment in lease changed year-over-year?: Beam Therapeutics's net investment in lease decreased by 4.0% year-over-year, from $102.22M to $98.15M.
What is the long-term trend for Beam Therapeutics's net investment in lease?: Over 5 years (2020 to 2025), Beam Therapeutics's net investment in lease has grown at a 3.0% compound annual growth rate (CAGR), from $86.86M to $100.68M.